Fair Value Measurement - Additional Information (Details) $ / shares in Units, $ in Millions		3 Months Ended		9 Months Ended
	Jun. 27, 2025 $ / shares shares	Sep. 30, 2025 USD ($)	Mar. 31, 2025 USD ($)	Sep. 30, 2025 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Percentage of outstanding debt covered by swaps		50.00%		50.00%
Agreeing to file register statement (in days)	45 days
Warrants value | $		$ 2.9		$ 2.9
Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loss on warrants | $		$ 0.3		$ 0.3
Prior Term Loan due 2027 | Domestic Line of Credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant term	5 years
Warrants to purchase common stock (in shares) | shares	3,934,776
Right to repurchase percentage (as a percent)	0.50
Prior Term Loan due 2027 | Domestic Line of Credit | Debt Instrument, Redemption, Period One
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Right to repurchase percentage (as a percent)	0.50
Prior Term Loan due 2027 | Domestic Line of Credit | Vesting period 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Exercise price (in usd per share)	$ 1.52
Prior Term Loan due 2027 | Domestic Line of Credit | Vesting period 1 | Debt Instrument, Redemption, Period One
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Exercise price (in usd per share)	1.40
Prior Term Loan due 2027 | Domestic Line of Credit | Vesting period 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Exercise price (in usd per share)	2.07
Prior Term Loan due 2027 | Domestic Line of Credit | Vesting period 2 | Debt Instrument, Redemption, Period One
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Exercise price (in usd per share)	$ 1.00
Interest rate swap agreements
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from settlement of derivative contract | $			$ 0.6